Cargando…
Toxicity spectrum of immunotherapy in advanced lung cancer: A safety analysis from clinical trials and a pharmacovigilance system
BACKGROUND: With the increased use of immune checkpoint inhibitors (ICIs) in advanced lung cancer, adverse events (AEs), particularly immune-related AEs (irAEs), have garnered considerable interest. We conducted a comprehensive assessment of the toxicity profile in advanced lung cancer using multi-s...
Autores principales: | Yan, Yi-Dan, Zhao, Ying, Zhang, Chi, Fu, Jie, Su, Ying-Jie, Cui, Xiang-Li, Ma, Er-Li, Liu, Bing-Long, Gu, Zhi-Chun, Lin, Hou-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256649/ https://www.ncbi.nlm.nih.gov/pubmed/35812997 http://dx.doi.org/10.1016/j.eclinm.2022.101535 |
Ejemplares similares
-
A Network Comparison on Safety Profiling of Immune Checkpoint Inhibitors in Advanced Lung Cancer
por: Yan, Yi-Dan, et al.
Publicado: (2021) -
Pharmacovigilance: Safety matters…
por: Biswas, Pipasha
Publicado: (2008) -
Big data, medicines safety and pharmacovigilance
por: Hussain, Rabia
Publicado: (2021) -
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
por: Yue, Qun-Ying
Publicado: (2021) -
Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies—pharmacovigilance database analysis with real-world data validation
por: Guo, Xue-Jun, et al.
Publicado: (2023)